CDH1 and breast carcinoma: A point not to be neglected within the increased testing, is the “awareness”, e.g., in breast centers; if the lobular subtype is present, a positive family history for breast cancer and a negativity of the standard markers (BRCA1/2) is an indication for sequencing CDH1 and also CTNNA1 in case of CDH1 negativity.